Keywords
Polycystic ovary syndrome; PCOS; Polycystic; Ovarian; Rotterdam criteria; Serum-AMH; Women’s health; Reproductive health
Abstract
Polycystic ovary (ovarian) syndrome, or PCOS is predominantly a reproductive health issue affecting women of reproductive age, though argued it can be defined as young as age 13 and through to early premenopausal age cohorts. Currently, the Rotterdam criteria are used in PCOS diagnosis: However, new research and understanding suggest that this method is since outdated from its original 2003 definition. However, no systematic research has been conducted that fully generalizes women globally affected by PCOS. The use of serum-AMH in diagnosis of PCOS reveals a higher sensitivity (92) and specificity (97) level than those of the Rotterdam criteria; 81 and 92 percent respectively. The contrast between these two opposing methods of diagnosis creates a large gap in PCOS prevalence worldwide, with serum-AMH suggesting nearly 23 percent of women globally being affected by PCOS, opposed to the 16 percent based upon current methods. The purpose of this proposal is to provide just because for redefining diagnostic techniques, in association with PCOS globally, using serum-AMH levels as PCOS markers versus morphology. By conducting an initial online survey with the option to participate in serum level and follicle counting tests, a more global view of PCOS and PCOS diagnosis methods/tools can potentially be seen. Furthermore, a call to change how PCOS is approached on a diagnostic level could potentially be found in accordance with a wider spanning study population.
Citation
Plouffé J. Polycystic Ovary Syndrome: An Epidemic in Women’s Health and Why it Matters. SM J Endocrinol Metab. 2017;3(1):1016s.